| Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications MS Castaneto, DA Gorelick, NA Desrosiers, RL Hartman, S Pirard, ... Drug and alcohol dependence 144, 12-41, 2014 | 859 | 2014 |
| Predicted Effector Molecules in the Salivary Secretome of the Pea Aphid (Acyrthosiphon pisum): A Dual Transcriptomic/Proteomic Approach JC Carolan, D Caragea, KT Reardon, NS Mutti, N Dittmer, K Pappan, ... Journal of proteome research 10 (4), 1505-1518, 2011 | 261 | 2011 |
| Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography–high resolution mass spectrometry and library matching M Concheiro, M Castaneto, R Kronstrand, MA Huestis Journal of Chromatography A 1397, 32-42, 2015 | 150 | 2015 |
| Pentylindole/pentylindazole synthetic cannabinoids and their 5-fluoro analogs produce different primary metabolites: metabolite profiling for AB-PINACA and 5F-AB-PINACA A Wohlfarth, MS Castaneto, M Zhu, S Pang, KB Scheidweiler, ... The AAPS journal 17, 660-677, 2015 | 133 | 2015 |
| Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices MS Castaneto, A Wohlfarth, NA Desrosiers, RL Hartman, DA Gorelick, ... Drug metabolism reviews 47 (2), 124-174, 2015 | 132 | 2015 |
| Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology KN Ellefsen, S Anizan, MS Castaneto, NA Desrosiers, TM Martin, ... Drug testing and analysis 6 (7-8), 728-738, 2014 | 87 | 2014 |
| Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry MS Castaneto, A Wohlfarth, S Pang, M Zhu, KB Scheidweiler, ... Forensic Toxicology 33, 295-310, 2015 | 84 | 2015 |
| High‐resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide … AS Gandhi, A Wohlfarth, M Zhu, S Pang, M Castaneto, KB Scheidweiler, ... Drug testing and analysis 7 (3), 187-198, 2015 | 53 | 2015 |
| Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens MS Castaneto, KB Scheidweiler, A Gandhi, A Wohlfarth, KL Klette, ... Drug Testing and Analysis 7 (6), 483-493, 2015 | 50 | 2015 |
| Metabolic characterization of AH‐7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction … A Wohlfarth, KB Scheidweiler, S Pang, M Zhu, M Castaneto, R Kronstrand, ... Drug testing and analysis 8 (8), 779-791, 2016 | 49 | 2016 |
| Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids E Spinelli, AJ Barnes, S Young, MS Castaneto, TM Martin, KL Klette, ... Drug testing and analysis 7 (6), 467-474, 2015 | 43 | 2015 |
| Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine … A Wohlfarth, KB Scheidweiler, M Castaneto, AS Gandhi, NA Desrosiers, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (3), 423-434, 2015 | 39 | 2015 |
| Identifying methamphetamine exposure in children MS Castaneto, AJ Barnes, KB Scheidweiler, M Schaffer, KK Rogers, ... Therapeutic drug monitoring 35 (6), 823-830, 2013 | 30 | 2013 |
| Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing MS Castaneto, AJ Barnes, M Concheiro, KL Klette, TA Martin, MA Huestis Analytical and Bioanalytical Chemistry 407, 4639-4648, 2015 | 26 | 2015 |
| Method validation of the biochip array technology for synthetic cannabinoids detection in urine MS Castaneto, NA Desrosiers, K Ellefsen, S Anizan, TM Martin, KL Klette, ... Bioanalysis 6 (21), 2919-2930, 2014 | 24 | 2014 |
| Metabolic profiling of synthetic cannabinoid 5F‐ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra‐high … BC Presley, MS Castaneto, BK Logan, SA Jansen‐Varnum Rapid Communications in Mass Spectrometry 34 (22), e8908, 2020 | 18 | 2020 |
| Assessment of synthetic cannabinoid FUB‐AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC–MS/MS BC Presley, MS Castaneto, BK Logan, SA Jansen‐Varnum Biomedical Chromatography 34 (9), e4884, 2020 | 16 | 2020 |
| Can synthetic urine replace authentic urine to “beat” workplace drug testing? VJ Kim, CK Okano, CR Osborne, DM Frank, CT Meana, MS Castaneto Drug testing and analysis 11 (2), 331-335, 2019 | 15 | 2019 |
| Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography–Mass Spectrometry D Battal, AJ Barnes, MS Castaneto, TM Martin, KL Klette, MA Huestis Therapeutic Drug Monitoring 37 (6), 805-811, 2015 | 7 | 2015 |
| Impact of cannabis‐infused edibles on public safety and regulation A Peralt, P Ke, MS Castaneto Journal of forensic sciences 67 (6), 2387-2393, 2022 | 6 | 2022 |
